Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Medicinal Chemistry

• Publication date

  2007-09-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/092986707782023217PMID 17979717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.

  2007cited by this paper
• Preparation of secolycorines against acetylcholinesterase.

  2007cited by this paper
• Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.

  2007cited by this paper
• Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.

  2007cited by this paper
• Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.

  2006cited by this paper
• Oxidative stress in Alzheimer patients in different stages of the disease.

  2006cited by this paper
• Isolation and cholinesterase-inhibition studies of sterols from Haloxylon recurvum.

  2006cited by this paper
• Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.

  2006cited by this paper
• Synthesis and pharmacology of galantamine.

  2006cited by this paper
• Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase.

  2006cited by this paper
• Dimeric and hybrid anti-Alzheimer drug candidates.

  2006cited by this paper
• Therapeutic approaches to Alzheimer's disease.

  2006cited by this paper
• Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.

  2006cited by this paper
• Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-alzheimer drug ganstigmine (CHF-2819).

  2006cited by this paper
• Synthesis and biological evaluation of new 4H-pyrano[2,3-b]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals.

  2006cited by this paper
• Isoquinoline derivatives as potential acetylcholinesterase inhibitors.

  2006cited by this paper
• Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.

  2006cited by this paper
• Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.

  2006cited by this paper
• Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.

  2006cited by this paper
• Search for dual function inhibitors for Alzheimer's disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Abeta fibril formation inhibition capacity.

  2006cited by this paper
• Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.

  2006cited by this paper
• Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.

  2006cited by this paper
• The role of acetylcholine in learning and memory.

  2006cited by this paper
• Bis-huperzine B: highly potent and selective acetylcholinesterase inhibitors.

  2005cited by this paper
• Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.

  2005cited by this paper
• Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.

  2005cited by this paper
• p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors.

  2005cited by this paper
• Isoterreulactone A, a novel meroterpenoid with anti-acetylcholinesterase activity produced by Aspergillus terreus.

  2005cited by this paper
• A rate determining step change in the pre-steady state of acetylcholinesterase inhibitions by 1,n-alkane-di-N-butylcarbamates.

  2005cited by this paper
• Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.

  2005cited by this paper
• Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze

  2005cited by this paper
• Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.

  2005cited by this paper
• Rational approach to discover multipotent anti-Alzheimer drugs.

  2005cited by this paper
• Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues.

  2005cited by this paper
• Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.

  2005cited by this paper
• Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties.

  2005cited by this paper
• Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE.

  2005cited by this paper
• New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids.

  2005cited by this paper
• Novel acetylcholinesterase inhibitor as increasing agent on rhythmic bladder contractions: SAR of 8-{3-[1-(3-fluorobenzyl)piperidin-4-yl]propanoyl}-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one (TAK-802) and related compounds.

  2005cited by this paper
• Synthesis of tricyclic analogs of stephaoxocanidine and their evaluation as acetylcholinesterase inhibitors.

  2005cited by this paper
• 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.

  2005cited by this paper
• Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.

  2005cited by this paper
• Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.

  2005cited by this paper
• Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.

  2005cited by this paper
• Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine.

  2005cited by this paper
• Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme.

  2005cited by this paper
• Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.

  2005cited by this paper
• Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors.

  2005cited by this paper
• Synthesis and acetylcholinesterase inhibition of derivatives of huperzine B.

  2005cited by this paper
• Acetylcholinesterase inhibition in Alzheimer's Disease.

  2004cited by this paper
• Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.

  2004cited by this paper
• Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.

  2004cited by this paper
• Acetylcholinesterase inhibitors: novel activities of old molecules.

  2004cited by this paper
• Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics.

  2004cited by this paper
• Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.

  2004cited by this paper
• Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease

  2004cited by this paper
• Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors.

  2004cited by this paper
• Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.

  2004cited by this paper
• Cholinesterase inhibitors: new roles and therapeutic alternatives.

  2004cited by this paper
• Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids.

  2003cited by this paper
• Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors.

  2003cited by this paper
• Design, synthesis and structure-activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.

  2003cited by this paper
• Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase.

  2003cited by this paper
• Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

  2003cited by this paper
• Neurobiology of butyrylcholinesterase

  2003cited by this paper
• Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional chinese medicine origin for the treatment of Alzheimer's disease.

  2003cited by this paper
• Synthesis and biological activity of pyridinium‐type acetylcholinesterase inhibitors

  2003cited by this paper
• Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna.

  2003cited by this paper
• Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

  2003cited by this paper
• Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease

  2003cited by this paper
• A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.

  2003cited by this paper
• Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives.

  2003cited by this paper
• Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.

  2003cited by this paper
• Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.

  2003cited by this paper
• Synthesis, Biological Activity, and Docking Studies of New Acetylcholinesterase Inhibitors of the Bispyridinium Type

  2003cited by this paper
• 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.

  2003cited by this paper
• Wnt signaling involvement in beta-amyloid-dependent neurodegeneration.

  2002cited by this paper
• Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit

  2002cited by this paper
• Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.

  2002cited by this paper
• Synthesis and Acetylcholinesterase/Butyrylcholinesterase Inhibition Activity of 4‐Amino‐2, 3‐diaryl‐5, 6, 7, 8‐tetrahydrofuro(and thieno)[2, 3‐b]‐quinolines, and 4‐Amino‐5, 6, 7, 8, 9‐pentahydro‐2, 3‐diphenylcyclohepta[e]furo(and thieno)‐[2, 3‐b]pyridines

  2002cited by this paper
• Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease.

  2002cited by this paper
• Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine.

  2002cited by this paper
• Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.

  2002cited by this paper
• Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase.

  2001cited by this paper
• Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues.

  2001cited by this paper
• Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?

  2001cited by this paper
• Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.

  2001cited by this paper
• Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.

  2001cited by this paper
• Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors.

  2000cited by this paper
• Abnormal tau-containing filaments in neurodegenerative diseases.

  2000cited by this paper
• Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).

  2000cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study.

  2000cited by this paper
• Molecular recognition by acetylcholinesterase at the peripheral anionic site: structure-activity relationships for inhibitions by aryl carbamates.

  1999cited by this paper
• Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.

  1999cited by this paper
• Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

  1998cited by this paper
• Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.

  1998cited by this paper
• Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.

  1998cited by this paper
• Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series.

  1998cited by this paper
• Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

  1996cited by this paper

• Spirodelae Herba ethanol extract attenuates neurotoxicity in hippocampal cells and improves scopolamine-induced cognitive impairment in mice

  2025cites this paper
• Diverse synthetic approaches to 3-arylmethylidene- and bis-3,5-arylmethylidene-N-benzylpiperidin-4-ones with thiophene scaffolds: The comparative experimental study

  2025cites this paper
• New Sulfonate Ester‐Linked Fluorinated Hydrazone Derivatives as Multitarget Carbonic Anhydrase and Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, Molecular Docking and ADME Analysis

  2024cites this paper
• Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease

  2024cites this paper
• Unnatural Phosphorus‐Containing α‐Amino Acids and Their N‐FMOC Derivatives: Synthesis and In Vitro Investigation of Anticholinesterase Activity

  2024cites this paper
• A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD).

  2024cites this paper
• Synthesis, Docking and Acetylcholinesterase Inhibitory Evaluation of 1,3,4-Thiadiazole Derivatives as Potential Anti-Alzheimer Agents

  2024cites this paper
• Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors

  2024cites this paper
• Stem cells in central nervous system diseases: Promising therapeutic strategies.

  2023cites this paper
• Design, Synthesis, and Pharmacological Evaluation of Novel Tacrine Derivatives as Multi-target ANTI-Alzheimer's Agents In Rat Models.

  2023cites this paper
• Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes

  2023cites this paper
• Acetylcholinesterase-responsive fluorescent probe: Recent advances from development to applications

  2023cites this paper
• In-silico investigations of novel tacrine derivatives potency against Alzheimer's disease

  2023cites this paper
• The mismatch negativity as an index of cognitive abilities in adults with Down syndrome

  2023cites this paper
• Integrating Effect-Directed Analysis and Chemically Indicative Mass Spectral Fragmentation to Screen for Toxic Organophosphorus Compounds.

  2023cites this paper
• Synthesis and Acetylcholinesterase Inhibitory Evaluation of Coumarin‐Linked Carbazole Derivatives

  2023cites this paper
• Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms

  2023cites this paper
• Study of Chemical Composition, Anticholinesterase and Antioxidant Properties of Essential Oil and Ethanolic Extract from Thymus Numidicus Poiret, an Algerian Endemic Medicinal Plant

  2023cites this paper
• Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia

  2022cites this paper
• Monitoring the Activity and Inhibition of Cholinesterase Enzymes using Single-Walled Carbon Nanotube Fluorescent Sensors

  2022cites this paper
• Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease

  2022cites this paper
• Neuroprotective Effect and Antioxidant Potency of Fermented Cultured Wild Ginseng Root Extracts of Panax ginseng C.A. Meyer in Mice

  2021cites this paper
• Anticholinesterase Activities of Different Solvent Extracts of Brewer’s Spent Grain

  2021cites this paper
• Effect of Piper Betle Leaf Extracts on Enhancement of Memory and Learning in Rodents

  2021cites this paper
• Design, Synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity.

  2021cites this paper
• Review—Recent Advances in FSCV Detection of Neurochemicals via Waveform and Carbon Microelectrode Modification

  2021cites this paper
• Intracerebral Transplantation of Neural Stem Cells Restores Manganese-Induced Cognitive Deficits in Mice

  2021cites this paper
• Donecopride, a Swiss army knife with potential interest against Alzheimer's disease

  2021cites this paper
• Evaluation of neuroprotective activity of isolated fraction from Biophytum sensitivum on #945;-(hydroxymethyl) Benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo non-7-yl ester induced dementia in rats

  2020cites this paper
• Nootropic and neuroprotective effects of ethanol extract of Vateria indica L bark on scopolamine-induced cognitive deficit in mice

  2020cites this paper
• Inhibitory activity on cholinesterases produced by aryl-phthalimide derivatives: green synthesis, in silico and in vitro evaluation

  2020cites this paper
• A Comparative Study of Methanolic and Hydro-Alcoholic Extracts of Moringa Oleifera Pods on Memory Enhancing Activity

  2020cites this paper
• Human Neural Stem Cells Encoding ChAT Gene Restore Cognitive Function via Acetylcholine Synthesis, Aβ Elimination, and Neuroregeneration in APPswe/PS1dE9 Mice

  2020cites this paper
• Aster glehni Extract Ameliorates Scopolamine-Induced Cognitive Impairment in Mice

  2019cites this paper
• Investigation of potent inhibitors of cholinesterase based on thiourea and pyrazoline derivatives: Synthesis, inhibition assay and molecular modeling studies.

  2019cites this paper
• Recent advances in multi-target anti-Alzheimer disease compounds (2013 up to present).

  2019cites this paper
• The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes.

  2019cites this paper
• Quantitative determination of talatisamine and its pharmacokinetics and bioavailability in mouse plasma by UPLC-MS/MS.

  2019cites this paper
• Synthesis, physicochemical and biological evaluation of tacrine derivative labeled with technetium-99m and gallium-68 as a prospective diagnostic tool for early diagnosis of Alzheimer's disease.

  2019cites this paper
• The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease.

  2019cites this paper
• Donecopride, a Swiss army knife with potential against Alzheimer's disease

  2019cites this paper
• Yuccalechins A–C from the Yucca schidigera Roezl ex Ortgies Bark: Elucidation of the Relative and Absolute Configurations of Three New Spirobiflavonoids and Their Cholinesterase Inhibitory Activities

  2019influential citation
• Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery.

  2018cites this paper
• Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors

  2018cites this paper
• Intramolecular cyclization of polyfluoroalkyl-containing 2-(arylhydrazinylidene)-1,3-diketones

  2018cites this paper
• Isoindolines/isoindoline-1,3-diones as AChE inhibitors against Alzheimer’s disease, evaluated by an improved ultra-micro assay

  2018influential citation
• Intracellular distribution of new tacrine analogues as a potential cause of their cytotoxicity against human neuroblastoma cells SH-SY5Y

  2018cites this paper
• Crystal structure, DFT calculations and evaluation of 2-(2-(3,4-dimethoxyphenyl)ethyl)isoindoline-1,3-dione as AChE inhibitor

  2018cites this paper
• Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease

  2018cites this paper
• Effect of donepezil on Hcy level in serum of Alzheimer's disease patients and correlation analysis of Hcy and dyssomnia

  2018cites this paper
• Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)-Platinum(II) Polypyridyl Complexes.

  2018cites this paper
• Amelioration of Scopolamine-Induced Learning and Memory Impairment by α-Pinene in C57BL/6 Mice

  2017cites this paper
• Ginger Components as Anti‐Alzheimer Drugs

  2017cites this paper
• The contribution of transgenic and nontransgenic animal models in Alzheimer’s disease drug research and development

  2017cites this paper
• Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase.

  2017cites this paper
• Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.

  2017cites this paper
• Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease

  2017cites this paper
• A silk peptide fraction restores cognitive function in AF64A‐induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene

  2017cites this paper
• Neuroprotective Effect of Green Synthesized Iron Oxide Nanoparticles Using Aqueous Extract of Convolvulus Pluricaulis Plant in The Management of Alzheimer’s Disease

  2017cites this paper
• Docking Studies for Multi-Target Drugs.

  2017cites this paper
• Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.

  2017cites this paper
• Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level.

  2017cites this paper
• Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.

  2017cites this paper
• An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds.

  2017cites this paper
• Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes

  2017cites this paper
• Expression pattern of NMDA receptors reveals antiepileptic potential of apigenin 8-C-glucoside and chlorogenic acid in pilocarpine induced epileptic mice.

  2016cites this paper
• A novel nano-optical sensing approach for real-time amyloid aggregation monitoring

  2016cites this paper
• Activation of endocannabinoid system in the rat basolateral amygdala improved scopolamine-induced memory consolidation impairment.

  2016cites this paper
• Regenerative Medicine in the Central Nervous System: Stem Cell-Based Cell- and Gene-Therapy

  2016cites this paper
• The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats.

  2016cites this paper
• History of Neural Stem Cell Research and Its Clinical Application

  2016cites this paper
• Synthesis and studies of biological activity of N-(4-tert-butylbenzyl)-N-(pyridin-3-ylmethyl)-2-aminothiazolines as potential multifunctional agents for treatment of neurodegenerative diseases

  2016cites this paper
• Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase

  2016cites this paper
• The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.

  2016cites this paper
• Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties.

  2015cites this paper
• Synthesis and investigation of biological activity of phosphorylated amines and amides

  2015cites this paper
• Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines

  2015cites this paper
• Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.

  2015cites this paper
• Electroacupuncture Suppressed Neuronal Apoptosis and Improved Cognitive Impairment in the AD Model Rats Possibly via Downregulation of Notch Signaling Pathway

  2015cites this paper
• Rat hormone sensitive lipase inhibition by cyclipostins and their analogs.

  2015cites this paper
• SERICIN AS A CHOLINERGIC MODULATOR IN ALZEIMER’S DISEASE INDUCED RAT

  2015cites this paper
• In vivo histamine voltammetry in the mouse premammillary nucleus.

  2015cites this paper
• Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases.

  2015cites this paper
• Nörodejeneratif Hastaliklarda Mezenkimal Kök Hücre Uygulamalari Application of Mesenchymal Stem Cells in Neurodegenerative Diseases

  2015cites this paper
• Human Olfactory Bulb Neural Stem Cells expressing hNGF Restore Cognitive Deficit in Alzheimer's Disease Rat Model

  2015cites this paper
• Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer’s Disease via Enhancing Neuron Differentiation and Paracrine Action

  2015cites this paper
• ginger components as new leads for the design and development of novel multi-targeted anti-alzheimer’s drugs: a computational investigation

  2014influential citation
• Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer's Disease

  2014cites this paper
• Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality

  2014cites this paper
• Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.

  2014cites this paper
• Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase

  2014cites this paper
• Design, Synthesis, Docking Study and Biological Evaluation of Some Novel Tetrahydrochromeno [3′,4′:5,6]Pyrano[2,3‐b]quinolin‐6(7H)‐one Derivatives Against Acetyl‐ and Butyrylcholinesterase.

  2014influential citation
• Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer’s drugs: a computational investigation

  2014influential citation
• ginger components as new leads for the design and development of novel multi-targeted anti-alzheimer’s drugs: a computational investigation

  2014influential citation
• Effects of neural stem cells on synaptic proteins and memory in a mouse model of Alzheimer's disease

  2014cites this paper
• Arşiv Kaynak Tarama Dergisi Archives Medical Review Journal

  2014cites this paper
• Neuroprotective effect of anthocyanins on acetylcholinesterase activity and attenuation of scopolamine‐induced amnesia in rats

  2014cites this paper
• Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.

  2014cites this paper
• Silk protein, sericin as a cognitive enhancer in Alzheimer?s disease

  2014cites this paper
• Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an APP/PS1 Double Transgenic Model of Alzheimer’s Disease

  2014cites this paper